Skip to content
  • Investor Dashboard
  • Manufacturing
BioStem logoBioStem logo
  • Home
  • Our Science
  • ProductsExpand
    • VENDAJE®
    • VENDAJE AC®
    • VENDAJE OPTIC®
    • American Amnion
  • Resources
  • About UsExpand
    • Careers
    • Events
CONTACT US

Investor Dashboard | Manufacturing

BioStem logo

  • Blog

    The Future of Chronic Wound Care: What to Expect in 2025

    ByJohn Garica December 16, 2024December 16, 2024

    As we look ahead to 2025, the landscape of chronic wound care is poised for remarkable advancements. Emerging technologies and innovative approaches promise to reshape how wounds are managed, with…

    Read More The Future of Chronic Wound Care: What to Expect in 2025Continue

  • Press Release

    BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts

    ByJohn Garica November 25, 2024April 14, 2025

    Nov 25, 2024Company continues to advance its placental-derived product portfolio with the first patent granted in the fenestrated wound care market POMPANO BEACH, Fla., Nov. 25, 2024 (GLOBE NEWSWIRE) — BioStem…

    Read More BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental AllograftsContinue

  • Press Release

    Zacks Research Report: BSEM Continues to Exceed Expectations

    ByJohn Garica November 14, 2024April 14, 2025

    11/13/2024 By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT BioStem Technologies, Inc. (OTC:BSEM) is a leading innovator focused on harnessing the natural properties of perinatal tissue in the…

    Read More Zacks Research Report: BSEM Continues to Exceed ExpectationsContinue

  • Press Release

    BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

    ByJohn Garica October 30, 2024April 14, 2025

    The pricing announcement from the Center for Medicare Services became effective on October 1, 2024, and allows BioStem to begin marketing initiatives with Venture Medical POMPANO BEACH, Fla., Oct. 29,…

    Read More BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) RegionsContinue

  • Press Release

    BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment

    ByJohn Garica October 21, 2024April 14, 2025

    Retrospective Study demonstrates clinical efficacy and statistical support for tissue processed via BioREtain to care for treatment-resistant chronic wounds Study published in the peer-reviewed journal, ‘International Wound Journal’ POMPANO BEACH,…

    Read More BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care TreatmentContinue

  • Blog

    Understanding Hypergranulation: Causes, Effects, and Treatment

    ByJohn Garica September 5, 2024September 5, 2024

    Hypergranulation is a term used to describe excessive granulation tissue formation at the site of a wound. While some granulation tissue is essential for wound healing, an overabundance can lead…

    Read More Understanding Hypergranulation: Causes, Effects, and TreatmentContinue

  • Press Release

    BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET

    ByJohn Garica August 29, 2024August 29, 2024

    Advanced wound care MedTech company recently reported a record second-quarter with $116.4M in revenue for H1, 2024 POMPANO BEACH, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC:…

    Read More BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ETContinue

  • Blog

    Multidisciplinary Care for Chronic Wounds

    ByJohn Garica August 29, 2024August 30, 2024

    Chronic wounds, which are wounds that do not heal in the expected time frame (usually about three months), require specialized treatment strategies. Here are some of the most common treatment…

    Read More Multidisciplinary Care for Chronic WoundsContinue

  • Blog

    The Transformative Impact of Effective Wound Care on the Lives of Patients  

    ByJohn Garica August 13, 2024August 16, 2024

    Wounds, whether acute or chronic, significantly impact a patient’s quality of life. They can affect physical, emotional, and social well-being, leading to prolonged suffering and diminished life satisfaction. However, advancements…

    Read More The Transformative Impact of Effective Wound Care on the Lives of Patients  Continue

  • Blog

    Biologics in Wound Care 

    ByJohn Garica July 10, 2024August 9, 2024

    Biologics are products derived from living cells or organisms that mimic natural substances in the body to promote healing. They address various aspects of wound healing, including cellular growth, extracellular…

    Read More Biologics in Wound Care Continue

Page navigation

Previous PagePrevious 1 … 3 4 5 6 Next PageNext
BioStem Technologies
  • Home
  • Our Science
  • Products
  • Resources
  • About Us
  • Contact Us
  • Patents

© 2024 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.

For screen reader problems with this website, please call (954) 380-8342 for assistance.

Linkedin Instagram X

FAQs
Careers
Terms and Conditions
Privacy Policy
Shipping Policy
Refund Policy
Cookie Policy

  • Home
  • Our Science
  • Products
    • VENDAJE®
    • VENDAJE AC®
    • VENDAJE OPTIC®
    • American Amnion
  • Resources
  • About Us
    • Careers
    • Events